Maemondo M - Search Results

1

Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study.

Saito R, Sugawara S, Ko R, Azuma K, Morita R, Maemondo M, Oizumi S, Takahashi K, Kagamu H, Tsubata Y, Seike M, Kikuchi T, Okamoto I, Satoshi M, Asahina H, Tanaka K, Sugio K, Kobayashi K. Saito R, et al. Among authors: maemondo m. Eur J Cancer. 2023 May;185:83-93. doi: 10.1016/j.ejca.2023.02.023. Epub 2023 Mar 2. Eur J Cancer. 2023. PMID: 36966696 Free article. Clinical Trial.

2

Tyrosine kinase inhibitors as first-line treatment in NSCLC.

Maemondo M. Maemondo M. Lancet Oncol. 2016 May;17(5):541-3. doi: 10.1016/S1470-2045(16)30055-9. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301025 No abstract available.

3

Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.

Fujiwara H, Kubota T, Amaike H, Inada S, Takashima K, Atsuji K, Yoshimura M, Maemondo M, Narumi K, Nukiwa T, Matsumoto K, Nakamura T, Hagiwara A, Yamagishi H. Fujiwara H, et al. Among authors: maemondo m. Cancer Gene Ther. 2005 Feb;12(2):206-16. doi: 10.1038/sj.cgt.7700782. Cancer Gene Ther. 2005. PMID: 15486556

4

[Pulmonary veno-occlusive disease developed in a man given long-term treatment with anticancerous agents].

Maemondo M, Ebina A, Saitou K. Maemondo M, et al. Nihon Kokyuki Gakkai Zasshi. 1998 Sep;36(9):823-8. Nihon Kokyuki Gakkai Zasshi. 1998. PMID: 9866989 Japanese.

5

Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas.

Hirao S, Yamada Y, Koyama F, Fujimoto H, Takahama Y, Ueno M, Kamada K, Mizuno T, Maemondo M, Nukiwa T, Matsumoto K, Nakamura T, Nakajima Y. Hirao S, et al. Among authors: maemondo m. Cancer Gene Ther. 2002 Aug;9(8):700-7. doi: 10.1038/sj.cgt.7700482. Cancer Gene Ther. 2002. PMID: 12136432

6

[Necessary clinical laboratory tests for early diagnosis of severe pulmonary diseases].

Maemondo M. Maemondo M. Nihon Naika Gakkai Zasshi. 2005 Dec 10;94(12):2495-501. doi: 10.2169/naika.94.2495. Nihon Naika Gakkai Zasshi. 2005. PMID: 16419589 Review. Japanese. No abstract available.

7

[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 3. Chemotherapy for patients with non-small cell lung cancer, 2) Driver mutation and molecular-targeted therapy in lung cancer].

Maemondo M. Maemondo M. Nihon Naika Gakkai Zasshi. 2014 Jun 10;103(6):1314-21. doi: 10.2169/naika.103.1314. Nihon Naika Gakkai Zasshi. 2014. PMID: 25151796 Review. Japanese. No abstract available.

8

[Anti-RANKL antibody].

Fukuhara T, Maemondo M. Fukuhara T, et al. Among authors: maemondo m. Nihon Rinsho. 2015 Feb;73 Suppl 2:235-9. Nihon Rinsho. 2015. PMID: 25831759 Japanese. No abstract available.

9

Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells.

Kikuchi T, Maemondo M, Narumi K, Matsumoto K, Nakamura T, Nukiwa T. Kikuchi T, et al. Among authors: maemondo m. Blood. 2002 Dec 1;100(12):3950-9. doi: 10.1182/blood-2002-04-1096. Epub 2002 Jul 25. Blood. 2002. PMID: 12393687 Free article.

10

Severe acute interstitial pneumonia and gefitinib.

Inoue A, Saijo Y, Maemondo M, Gomi K, Tokue Y, Kimura Y, Ebina M, Kikuchi T, Moriya T, Nukiwa T. Inoue A, et al. Among authors: maemondo m. Lancet. 2003 Jan 11;361(9352):137-9. doi: 10.1016/S0140-6736(03)12190-3. Lancet. 2003. PMID: 12531582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters